Tom Ellman

Tom Ellman

Auto-generated profile, based on publicly available information

Tom Ellman

Affiliation Medecins Sans Frontieres, Southern African Medical Unit, Cape Town, South Africa

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
NFNathan Ford
Nathan Ford
EGElvin Geng
Elvin Geng
TETom Ellman
Tom Ellman
COCatherine Orrell
Catherine Orrell
PEPeter Ehrenkranz
Peter Ehrenkranz
HBHelen Bygrave
Helen Bygrave
Nathan Ford and co-authors discuss global priorities in the provision of HIV prevention and treatment services.

1 January 2019 in Global Health Action
Verified
Journal Article
Open access
MCMenard L. Chihana
Menard L. Chihana
HHHelena Huerga
Helena Huerga
GCGilles Van Cutsem
Gilles Van Cutsem
TETom Ellman
Tom Ellman
EGEric Goemaere
Eric Goemaere
MDMary-Ann Davies
Mary-Ann Davies
Background: Despite substantial progress in antiretroviral therapy (ART) scale up, some people living with HIV (PLHIV) continue to present with advanced HIV disease, contributing to ongoing HIV-related morbidity and mortality. Objective: We aimed to quantify population-level estimates of advanced HIV from three high HIV prevalence settings in Sub-Saharan Africa. Methods: Three cross-sectional surveys were conducted in (Ndhiwa (Kenya): September–November 2012), (Chiradzulu (Malawi): February–May 2013) and (Eshowe (South Africa): July–October 2013). Eligible individuals 15–59 years old who consented were interviewed at home followed by rapid HIV test and CD4 count test if tested HIV-positive. Advanced HIV was defined as CD4 < 200 cells/µl. We used logistic regression to identify patient characteristics associated with advanced HIV. Results: Among 18,991 (39.2% male) individuals, 4113 (21.7%) tested HIV-positive; 385/3957 (9.7% (95% Confidence Interval [CI]: 8.8–10.7)) had advanced HIV, ranging from 7.8% (95%CI 6.4–9.5) Chiradzulu (Malawi) to 11.8% (95%CI 9.8–14.2) Ndhiwa (Kenya). The proportion of PLHIV with advanced disease was higher among men 15.3% (95% CI 13.2–17.5) than women 7.5% (95%CI 6.6–8.6) p < 0.001. Overall, 62.7% of all individuals with advanced HIV were aware of their HIV status and 40.3% were currently on ART. Overall, 65.6% of individuals not on ART had not previously been diagnosed with HIV, while only 29.6% of those on ART had been on ART for ≥6 months. Individuals with advanced HIV disease were more likely to be men (adjusted Odds Ratio [aOR]; 2.1 (95%CI 1.7–2.6), and more likely not to be on ART (aOR; 1.7 (95%CI 1.3–2.1). Conclusion: In our study, about 1 in 10 PLHIV had advanced HIV with nearly 40% of them unaware of their HIV status. However, a substantial proportion of patients with advanced HIV were established on ART. Our findings suggest the need for a dual focus on alternative testing strategies to identify PLHIV earlier as well as improving ART retention.

1 October 2013 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Open access
PPPieter Pannus
Pieter Pannus
EFEmmanuel Fajardo
Emmanuel Fajardo
CMCarol Metcalf
Carol Metcalf
RCRebecca M. Coulborn
Rebecca M. Coulborn
LDLaura T. Durán
Laura T. Durán
Wolfgang PreiserWolfgang Preiser
Wolfgang Preiser
Rollout of routine HIV-1 viral load monitoring is hampered by high costs and logistical difficulties associated with sample collection and transport. New strategies are needed to overcome these constraints. Dried blood spots from finger pricks have been shown to be more practical than the use of plasma specimens, and pooling strategies using plasma specimens have been demonstrated to be an efficient method to reduce costs. This study found that combination of finger-prick dried blood spots and a pooling strategy is a feasible and efficient option to reduce costs, while maintaining accuracy in the context of a district hospital in Malawi.

24 November 2021 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
ZNZibusiso Ndlovu
Zibusiso Ndlovu
TETom Ellman
Tom Ellman
Zibusiso Ndlovu and Tom Ellman discuss the potential value of task sharing in provision of testing for HIV and other infectious diseases.

26 July 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SBStéphanie Blaizot
Stéphanie Blaizot
HHHelena Huerga
Helena Huerga
BRBenjamin Riche
Benjamin Riche
TETom Ellman
Tom Ellman
ASAmir Shroufi
Amir Shroufi
RERené Ecochard
René Ecochard
Combined prevention interventions, including early antiretroviral therapy initiation, may substantially reduce HIV incidence in hyperendemic settings. Our aim was to assess the potential short-term impact of combined interventions on HIV spreading in the adult population of Mbongolwane and Eshowe (KwaZulu-Natal, South Africa) using sex- and age-specific scenarios, and age-targeted interventions. A mathematical model was used with data on adults (15–59 years) from the Mbongolwane and Eshowe HIV Impact in Population Survey to compare the effects of various interventions on the HIV incidence rate. These interventions included increase in antiretroviral therapy (ART) coverage with extended eligibility criteria, increase in voluntary medical male circumcision (VMMC), and implementation of pre-exposure prophylaxis (PrEP) among women. With no additional interventions to the ones in place at the time of the survey (ART at CD4 < 350 and VMMC), incidence will decrease by 24% compared to the baseline rate. The implementation of “ART at CD4<500” or “ART for all” would reduce further the incidence rate by additional 8% and 15% respectively by 4 years and 20% and 34% by 10 years. Impacts would be higher with age-targeted scenarios than without. In Mbongolwane and Eshowe, implementation of the new South African guidelines, recommending ART initiation regardless of CD4 count, would accelerate incidence reduction. In this setting, combining these guidelines, VMMC, and PrEP among young women could be an effective strategy in reducing the incidence to low levels.